Skip to content
MarketScale
‹ Back to IndustriesSciences

Demystifying DAF Sludge

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top? Do you remember the sound you heard when you twisted the cap? Odds are you know exactly what I’m talking about. But have you ever wondered exactly what’s going on…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Taylor Bagley ·
Share
Demystifying DAF Sludge

Key takeaways

01

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top?

02

Do you remember the sound you heard when you twisted the cap?

03

Odds are you know exactly what I’m talking about.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top? Do you remember the sound you heard when you twisted the cap? Odds are you know exactly what I’m talking about.

But have you ever wondered exactly what’s going on inside that bottle? If you’ve spent time around a protein processing plant or have worked at a wastewater treatment facility, you probably know the answer. Let’s take a closer look.

Why Is DAF, or Dissolved Air Flotation, Necessary?

The wastewater profession and its lingo are chock-full of acronyms. One of the best-known for a wastewater operator at a meat processing facility is “DAF,” pronounced “daf” or, sometimes, “D-A-F.” It stands for Dissolved Air Floatation, and it basically works like your soda bottle.

To understand this better, let me back up a little. Inside a poultry processing facility, meat is tossed, turned, tumbled, sliced, diced, washed and cut up. Throughout this process, very small bits of meat, fat and other proteins and fibrous particles are detached. This is the beginning of a long journey for these small particles.

The particles flow to a drain and mingle with other discarded parts of the chicken. Along with these larger chicken parts, like feet, heads, entrails and feathers, the small particles work their way to a screening room. Here, we often find large, rotating screens tasked with recovering valuable proteins, attached fats and feathers. These recovered materials are sent to rendering facilities and typically converted into different kinds of meals to be used as animal feed ingredients. The screens capture particles in the range of two hundredths (0.02) to four hundredths (0.04) of an inch and larger. The particles that pass through the screens then flow to wastewater for further treatment.

While it may sound like this water is a typical wastewater stream at this point, in fact, most conventional aerobic wastewater treatment plants cannot treat this water directly due to its high concentration of solids and nutrients. In most cases, to meet all state and federal discharge limits, additional reductions in loading must be achieved before reaching the wastewater plant’s biological treatment system.

How the DAF Does Its Job

Let’s come back around to the bottle of soda and the DAF. A DAF and its bubbles, like the ones you see rising to the top of your spda, will be just the ticket for cutting the loading to wastewater by 70-90%!

What you are observing when you open that bottle of carbonated drink is a result of a release of pressure built up inside the bottle. At the factory, the liquid was carbonated, meaning that CO2 was dissolved into your drink under pressure. Once you release that pressure, the CO2 starts to form gas bubbles, or, to be more technical, comes out of solution. This is exactly how a DAF works, only it uses ambient air injected directly into a waste stream under pressure to create the dissolved air, which will later be depressurized to reform gas bubbles.

But what is this accomplishing? Good question.

Remember the small bits of proteins and fats that made it through the screens? When pressure is released inside the DAF unit, the dissolved air starts to reform into very small air bubbles. As these bubbles rise to the surface, they attach to the small particles of solids suspended in the water, bringing them together and carrying them to the top. By doing this, the DAF system has removed the small particles that a screen could not.

Cool! What Now?

Now that that we have formed a semi-solid slurry (usually referred to as DAF Sludge or just Sludge), the DAF system scrapes the sludge into a collection hopper or tank, where it is ready for Denali to take over and turn this waste into gold. Not literal gold, of course, but something of value, for sure.

Now you understand that DAF Sludge is simply small bits of proteins, fats and fibrous materials that could not be removed by simple mechanical means. In the next blog, we will continue looking at the journey of these small particles and explain that, while small, they can still achieve greatness!

Until then, the next time you pop the top on your soda, remember there is more to the fizz than just a tingle to the taste buds.

To learn more about Denali’s beneficial use program, visit https://www.denaliwater.com/services/beneficial-use/.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

TB
Taylor Bagley

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

A September 2024 Cytotherapy paper describes a robotic cluster designed to automate manual steps in cell therapy manufacturing. Additional reviews published in 2019 and 2026, along with commentary from Genetic Engineering and Biotechnology News, discuss automation and AI as tools being explored for the cell and gene therapy manufacturing sector.

  • 01A robotic cluster combining a robotic arm with customized modules can handle standard cell therapy equipment (incubators, bioreactors, reagent bags) without requiring entirely new manufacturing platforms.
  • 02The system produced human CD8+ T cells with cell yields, viability and identity comparable to manual cultures while maintaining sterility, according to the Cytotherapy paper.
  • 03Manufacturing automation and AI are cited in industry analysis as potential solutions to skilled labor shortages and production scaling challenges, particularly for allogeneic therapies manufactured at larger scale.

Sep 13, 2026

Deloitte's Biopharma AI Value Estimates Come With a Timing Catch

Deloitte's Biopharma AI Value Estimates Come With a Timing Catch

Deloitte's 2024 report, covered by TechTarget in April 2024, estimated that a top-10 biopharma company could capture $5-7 billion in peak AI value over five years, with about 90% concentrated in R&D, manufacturing/supply chain, and commercial functions. McKinsey reported in November 2025 that despite rising AI investment, pharma companies have not yet seen shorter development timelines or better clinical success rates.

  • 01Deloitte estimates $5–7B peak AI value for top-10 biopharma firms over five years, with cost reductions appearing in 1–2 quarters and revenue gains taking 3–4 quarters.
  • 02McKinsey found pharma companies have not yet achieved shorter drug development timelines or improved preclinical and clinical success rates despite increased AI spending.
  • 03AI systems used in manufacturing, supply chain, and R&D functions may require validation under existing regulated systems frameworks like GAMP.

Sep 13, 2026

CPC Biotech, Multiply Labs Develop Robot-Ready Cell Therapy Connector

CPC Biotech, Multiply Labs Develop Robot-Ready Cell Therapy Connector

CPC Biotech, part of PSG and Dover, announced on May 27, 2026 that it is collaborating with Multiply Labs to develop an aseptic connector designed for robotic operation. The companies said the connector combines CPC's MicroCNX Nano Series with a proprietary interface engineered for robotic grippers, giving robots a consistent contact point during aseptic fluid transfers in Multiply Labs' closed cell and gene therapy processing systems.

  • 01Robotic grippers can reliably handle rigid parts but struggle with soft materials like bags and tubing, driving demand for robot-compatible connectors in sterile processing.
  • 02Commercial cell therapy production was under 5,000 doses per year in 2023 while global demand was estimated in the millions, creating manufacturing constraints.
  • 03Cell therapy manufacturing may involve upwards of 40 process steps, and optimal workflows remain under development without industrywide standardization.

Sep 10, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

TB
Taylor Bagley

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512